BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 21, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 15, 2005
View Archived Issues
CNS-5161 induces analgesic effects in patients with chronic neuropathic pain
Read More
Novel gene therapy for chronic pain targets glia / News in Context
Read More
Specific class II HDAC inhibitors for beta-thalassemia and sickle cell anemia treatment
Read More
KR-32570 improves functional and metabolic dysfunction post-ischemia
Read More
Neurocrine reviews pipeline progress
Read More
ISIS-301012 improves the lipid profile of patients with hypercholesterolemia
Read More
New data on the pharmacokinetics of dabigatran etexilate in humans
Read More
Acarbose shows promise in the treatment of renal disease
Read More
Phase II study under way with VX-702 for rheumatoid arthritis
Read More
Phase I study for Tarvacin in refractory advanced solid tumors
Read More
Cell Therapeutics sells Trisenox to Cephalon
Read More
Silodosin enters phase III in U.S. for BPH
Read More
Renovis ends phase Ia study of REN-850
Read More
FDA approves Adacel vaccine
Read More
Exelixis in transaction to fund development of drug candidates
Read More
Exelixis grants license to XL-119 to Helsinn Healthcare
Read More
U.S. Navy submits IND for Hemopure trauma trial
Read More
FDA agrees to rolling NDA for Virulizin
Read More
Non-approvable letter for Velac
Read More
AG-041R induces chondrogenesis via TGF-beta induction and MAPK activation
Read More
Dopamine D2 receptor ligands from Pfizer
Read More
Recent patents disclose novel treatments for HIV infection
Read More
New treatment options for respiratory and allergic disorders disclosed in recent patents
Read More
Low-dose PARP inhibitor combination therapy effective in early peripheral diabetic neuropathy
Read More
